[Treatment of intestinal helminthiases using a new drug combination: pyrantel pamoate and thiabendazole].
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006373:Helminthiasis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011715:Pyrantel / Q000031:analogs & derivatives*; D011716:Pyrantel Pamoate / Q000009:adverse effects / Q000627:therapeutic use*; D013607:Tablets; D013827:Thiabendazole / Q000009:adverse effects / Q000627:therapeutic use*
D004338:Drug Combinations; D013607:Tablets; D011715:Pyrantel; D011716:Pyrantel Pamoate; D013827:Thiabendazole
Tratamento das helmintíases intestinais com nova associação medicamentosa: pamoato de pirantel e tiabendazol.